Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Extended course of varenicline successful in late-quitters

By Nigel Praities

Smokers who struggle with their initial quit attempt may benefit from being offered an extended course of smoking cessation treatment, according to a US study.

The data, presented at the European Society of Cardiology this week, showed 35% of ‘late-quitters subsequently managed to quit following a second 12 week course of varenicline, despite quitting late in the course of a standard 12-week treatment course. This compared with the 23% of late-quitters who were put onto placebo after their initial quit attempt.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say